US FDA approves Innoviva's oral antibiotic for common sexually transmitted infections
12/12/2025 18:25
Dec 12 (Reuters) - The U.S. Food and Drug Administration has approved Innoviva's INVA.O oral antibiotic for common sexually transmitted infection, offering patients a pill instead of the injection that is currently the only recommended treatment, the regulator said on Friday. (Reporting by Kamal Choudhury and Padmanabhan Ananthan in Bengaluru; Editing by Krishna Chandra Eluri) ((Kamal.Choudhury@thomsonreuters.com;))
Recent news on Innoviva
See all newsInnoviva, Inc. reports results for the quarter ended June 30 - Earnings Summary
Innoviva Q2 revenue rises on higher net product sales
Brief: Innoviva Q2 Royalty Revenue USD 56.334 Million
Brief: Nortiva Bio Launches To Develop Long-Acting Oral Medicines
Brief: Innoviva Q1 Royalty Revenue USD 55.167 Million